Berberis Quartz NDC 48951-2054

NDC codes

FDA NDC Directory

Product NDC (as listed)48951-2054Labeler and product segments. Claims need a package NDC.

Product NDC at billing width48951-2054Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
48951-2054-1	48951205401	10 AMPULE in 1 BOX (48951-2054-1) / 1 mL in 1 AMPULEMarketed from Sep 1, 2009

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Berberis Quartz
Generic name (nonproprietary): berberis quartz
Active ingredients: Berberis vulgaris root bark — 3 [hp_X]/mLBos taurus nasal mucosa — 7 [hp_X]/mLSilicon dioxide — 20 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Uriel Pharmacy Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Sep 1, 2009
Listing expires: Dec 31, 2027
Identifiers: Product ID 48951-2054_48865336-9809-4f14-e063-6294a90a7c58SPL ID 48865336-9809-4f14-e063-6294a90a7c58SPL set ID 5da48d70-1140-495d-b672-0e55c04196e1UNII 1TH8Q20J0U, 343455G79K, ETJ7Z6XBU4

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N448951205401 followed by a unit qualifier and the quantity

Package 48951-2054-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 16, 2026.

Indications (excerpt from the label)

FOR OARL USE ONLY

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)